Medigen Vaccine Biologics Corp. (MVC) and Substipharm Biologics announced on March 17 that ENVACGEN®, an Enterovirus 71 (EV-A71) vaccine, has received marketing authorization from the Drug ...
Top Taiwan brand joins forces with Substipharm Biologics to expand South-East Asian market and help improve young children's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results